PTEN and Familial prostate cancer: Recognized chromosomal aberrations such as the TMPRSS2-ERG gene fusion, the gain of MYC, and the losses of TP53 and PTEN have been shown to be of prognostic value in prostate cancer [7,8,9,10,11].